Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion by unknown
Neutrophil Migration across Cultured Intestinal Epithelial Monolayers Is 
Modulated by Epithelial Exposure to IFN-3, in a Highly Polarized Fashion 
Scan P. Colgan,* Charles A. Parkos,* Charlene Delp,* M. Amin Arnaout,* and James L. Madara* 
*  Departments of Pathology, Brigham and Women's Hospital and Harvard Medical School; Harvard Digestive Diseases Center, 
Boston, Massachusetts 02115; and ~  Departments of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02138, 
and Harvard Medical School, Boston, Massachusetts 02115 
Abstract.  Neutrophil, or polymorphonuclear leuko- 
cyte (PMN),  migration across intestinal epithelial bar- 
riers,  such as occurs in many disease states, appears 
to result in modifications of epithelial barrier and ion 
transport functions (Nash,  S., J.  Stafford, and J.  L. 
Madara.  1987. Z  Clin.  Invest.  80:1104-1113;  Madara, 
J. L., C. A. Parkos, S. P. Colgan, R. J. MacLeod, S. 
Nash, J. B. Matthews, C. Delp, and W. I. Lencer. 
1992. J.  Clin.  Invest.  89:1938-1944).  Here we inves- 
tigate the effects of epithelial exposure to IFN-,), on 
PMN migration across cultured monolayers of the hu- 
man intestinal epithelial cell line Tu. Transepithelial 
migration of PMN was initially assessed in the apical- 
to-basolateral direction, since previous studies indicate 
general qualitative similarities between PMN migra- 
tion in the apical-to-basolateral and in the basolateral- 
to-apical directions. In the apical-to-basolateral direc- 
tion, epithelial exposure to IFN-.,/rnarkedly upregulated 
transepithelial migration of PMN in a dose- and time- 
dependent fashion as measured by both electrical and 
myeloperoxidase assays. This IFN-~/-elicited effect on 
transmigration was specifically due to a IFN-,/effect on 
epithelial cells and was not secondary to IFN-,y effects 
on epithelial tight junction permeability. Moreover, 
this IFN-.y effect was dependent on epithelial protein 
synthesis, and involved a pathway in which CDllb/18, 
but not ICAM-1 or CDlla/18,  appeared to play a cru- 
cial role in PMN-epithelial adhesion. IFN-~/also sub- 
stantially modified PMN transepithelial migration in 
the natural, basolateral-to-apical direction. The IFN-'y 
effect on naturally directed transmigration was also 
specifically due to an IFN-3, effect on epithelial cells, 
showed comparable time and dose dependency to that 
of oppositely directed migration, was CDllb/18 depen- 
dent, and required epithelial protein synthesis. Addi- 
tionally, however, important qualitative differences ex- 
isted in how IFN-3, affected transmigration in the two 
directions. In contrast to apical-to-basolateral directed 
migration, IFN-,), markedly downregulated trans- 
epithelial migration of PMN in the natural direction. 
This downregulation of PMN migration in the natural 
direction, however, was not due to failure of PMN to 
move across filters and into monolayers. Indeed, IFN-3, 
exposure to epithelia increased the number of PMN 
which had moved into the basolateral  space of the epi- 
thelium in naturally directed transmigration. These 
results represent the first detailed report of influences 
on PMN transepithelial migration by a cytokine, 
define conditions under which a qualitative difference 
in PMN transepithelial migration exists, and suggest 
that migration of PMN across epithelia in the natural 
direction may involve multiple steps which can be 
differentially regulated by cytokines. Specifically, it 
appears that in naturally directed migration, IFN-~/ 
may enhance the retention time of the recruited PMN 
in the paracellular space below tight junctions, and 
does so, at least in part, by downregulating a 
PMN-epithelial interactive event required for subse- 
quent transjunctional migration. We speculate that 
such retention of PMN at this specific anatomic loca- 
tion, the site wherein the transition from the external 
environment to the internal milieu occurs, may serve 
an important role in mucosal defense. 
early and crucial step in the acute inflammatory re- 
sponse  is  attachment of neutrophils  (PMN)t,  or 
polymorphonuclear leukocytes to endothelial sur- 
faces  and  subsequent  emigration  from  the  vasculature 
1. Abbreviations used in thispaper:  ANOVA, analysis of variance; CE, cell 
equivalents; FMLP, n-formyt-methionyt-leucyl-phenylalanine; PMN, poly- 
morphonuclear  leukocytes. 
(Springer, 1990; Osborn,  1990;  Pober and Cotran,  1990). 
In  inflammatory  diseases  of  organs  lined  by  columnar 
epithelia, however, the migration of PMN is not complete 
until PMN have also migrated across the epithelial surface 
(Yardley and Donowitz, 1977; Yardley, 1986).  While sub- 
stantial  progress has been made in the understanding of 
PMN-endothelial  interactions  (Arnaout  et  al.,  1988; 
Springer, 1990; Larson and Springer, 1990; Osborn, 1990; 
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information is available concerning PMN-epithelial interac- 
tions (Cramer et al.,  1986; Nash et al.,  1987,  1988;  Mig- 
liorisi et al.,  1988; Parkos et al.,  1991,  1992). However, it 
is likely that such PMN-epithelial  interactions  may be of 
substantial importance.  For example, we have recently de- 
scribed a neutrophil-derived  product which elicits electro- 
genic  CI-  secretion  (the basis  of mucosal  hydration  and, 
when upregulated in the intestine, the basis of secretory diar- 
rhea) (Donowitz and Welsh, 1987) from human crypt intesti- 
nal epithelial cell lines and from primary isolates of mam- 
malian crypt cells (Nash et al.,  1991; Madara et al.,  1992). 
This  neutrophil-derived  secretagogue  primarily  expresses 
bioactivity  when  presented  to  the  apical  rather  than  the 
basolateral plasma membrane of intestinal  epithelial  cells. 
From  such observations one can deduce that as a  conse- 
quence of transepithelial migration of PMN in such organs, 
many important biological signals may be elicited. 
PMN migration across intestinal epithelia is the hallmark 
of active intestinal inflammation and occurs in such disease 
states as ulcerative colitis,  Crohn's  disease,  and infectious 
enterocolitis (Yardley  and Donowitz,  1977;  Yardley,  1986). 
Transepithelial migration of PMN is particularly evident in 
the intestinal  crypt and eventuates in crypt abscess forma- 
tion-a characteristic of severe inflammatory disease (Yard- 
ley and  Donowitz,  1977;  Yardley,  1986).  In patients  with 
inflammatory bowel disease, the degree of PMN transepi- 
thelial migration, assessed quantitatively, has been shown to 
correlate with patients' symptoms as well as with the degree 
of intestinal epithelial barrier dysfunction, as assessed quan- 
titatively (Teahon et al.,  1991). Studies of human mucosa in 
such diseases  suggest that  PMN transepithelial  migration 
predates focal breakdown of the epithelial surface (Yardley 
and Donowitz, 1977; Yardley,  1986), and that defective epi- 
thelial barrier function also predates structural discontinui- 
ties in the mucosa (Hawker et al., 1980). As outlined above, 
such translocation  of PMN  across  still-intact  monolayers 
can,  by  exposure  of apical  membranes  to  a  neutrophil- 
derived  secretagogue  (Nash  et  al.,  1991;  Madara  et  al., 
1992), elicits fluid secretion from crypt epithelia. 
We have  previously  modeled  the  event of PMN  trans- 
migration using human peripheral blood neutrophils and cul- 
tured,  human~erived,  intestinal  epithelial  monolayers de- 
rived from the cell line %4  (Nash et al.,  1987;  Parkos et 
al.,  1991,  1992; Madara et al.,  1993). Such monolayers are 
composed of columnar epithelial cells with features similar 
to  those  of natural  crypt  epithelia  (Madara  and  Dharm- 
sathaphorn,  1985;  Madara  et al.,  1987).  These cells join 
neighbors  through  apical  circumferential  tight  junctions 
which maintain  structure-function  characteristics  found in 
fight junctions  of natural  epithelia  (Madara  and  Dharm- 
sathaphorn,  1985). Furthermore, these ceils have a polarized 
surface distribution  of the pumps,  channels,  and cotrans- 
porters which allow manifestation of electrogenic CI- secre- 
tion  (Dharmsathaphorn  and  Madara,  1990).  Lastly,  the 
regulation of ion transport events seen in T~ cells, both via 
direct manipulation  of intracellular  second messengers or 
indirectly through receptors for hormones or toxins (Dharm- 
sathaphorn and Madara,  1990), closely recapitulates regula- 
tory events seen in natural crypt epithelia. For these reasons, 
T~  cells are viewed as a  model  for haman  crypt epithe- 
lium-the  site at  which  the  bulk of PMN  transepithelial 
migration occurs in a variety of active inflammatory intesti- 
nal diseases (Yardley and Donowitz,  1977;  Yardley,  1986). 
Our prior studies using this epithelium as a model for exami- 
nation of PMN-intestinal  epithelial  interactions  have indi- 
cated that PMN transmigration  elicits a reversible decrease 
in transepithelial resistance due to impalement of intercellu- 
lar tight junctions (Nash et al.,  1987),  and requires PMN 
~2-integdns,  specifically  CDllb/CD18  (Parkos et al.,  1991, 
1992).  While we have shown that PMN transmigration  is 
quantitatively more efficient in the physiological (basolateral- 
to-apical) direction (Parkos et al.,  1991), qualitative differ- 
ences in transepithelial  migration,  relating to the direction 
of transmigration,  have generally not been found (Nash et 
al.,  1987,  1988; Parkos et al.,  1991). 
As is the case with endothelial-PMN interactions,  under 
natural  inflammatory  conditions,  PMN-epithelial  interac- 
tions often take place in the presence of lymphocyte-derived 
cytokines  (Yardley  and  Donowitz,  1977;  Yardley,  1986). 
While it is known that cytokines dramatically modulate the 
interactions  of neutrophils  with endothelial  cells (Osborn, 
1990; Pober and Cotran, 1990), essentially nothing is known 
concerning  the potential  for cytokine regulation of epithe- 
lial-neutrophil  interactions.  Others have shown that IFN-% 
the 40-kD homodimeric glycoprotein secreted by activated 
T  cells  (Trinchieri  and  Perussia,  1985),  is  a  dominant 
cytokine in human intestinal mucosa and is particularly en- 
riched in the intestine after antigenic challenge (Quiding et 
al.,  1991).  Thus,  IFN--~ is likely an important cytokine in 
the  intestinal  epithelial  microenvironment.  Epithelia,  in- 
cluding our model intestinal epithelial cell line (Madara and 
Stafford,  1989),  appear  to  express  receptors  for  IFN-% 
Lastly, IFN-3, appears capable of modulating the intestinal 
epithelial  cell surface with which a transmigrating  neutro- 
phil  must  interface.  For example,  IFN-v  exposure  elicits 
MHC  class  II  antigen  expression  on  intestinal  epithelia 
(Mayer et al.,  1991). 
Here we examine the effects of IFN-3, on transepithelial 
migration  of human  neutrophils  across  monolayers  of a 
cryptlike human intestinal epithelial cell line. IFN-3, is found 
to have substantial effects on PMN transepithelial migration, 
and thus, these data provide the first detailed description of 
cytokine modulation  of neutrophil-epithelial  interactions. 
We also find that the effects of IFN--y on PMN transepithelial 
migration  distinctly  differ depending  on  the  direction  of 
migration  of PMN across the epithelial  monolayer.  These 
latter data represent the first report of a qualitative difference 
in neutrophil-epithelial  monolayer interactions  relating  to 
the polarity of the interaction. 
Materials and Methods 
Antibodies 
Mouse ascitic fluids containing previously characterized functionally in- 
hibitory mAb to CDI8 (TS1/18, subclass IgGl),  CDlla (TS1/22,  subclass 
IgG0, CDllb (44a, subclass IgG2a), or CDllc (L29, subclass IgGl), were 
used as described previously (Parkos et al.,  1991,  1992). A control mAb 
directed against CDt0 05, subclass IgG2a) and previously shown to bind 
PMN (Ritz et al., 1980; Arnaout et al.,  1983), but not inhibit transmigra- 
tion (Parkos et al.,  1991), was used as a PMN binding control. All mAb 
were used at a  1:200 dilution in HBSS (containing Ca  2+ and Mg  2+, with 
10 mM Hepes, pH 7.4, Sigma Chem. Co., St. Louis, MO) during trans- 
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RR1/1 (Diamond et al., 1991) were generously provided by Dr. Robert Roth- 
lein (Boehringer Ingelheim Pharmaceuticals). 
Cell Culture 
Approximately 500 epithelial monolayers were used for these studies. T84 
intestinal epithelial cells (passages 70-95) were grown and maintained as 
confluent monolayers on collagen-coated permeable supports as previously 
described in detail  (Dharmsathaphorn and  Madara,  1990).  Monolayers 
were  grown  on  0.33-cm  2  ring-supported  polycarbonate  filters  (Costar 
Corp., Cambridge, MA) and utilized 6-14 d after plating as described previ- 
ously (Madara et al.,  1993).  Inverted monolayers, used to study trans- 
migration of PMN in the basolateral-to-apical direction were constructed 
as described before (Parkos et al., 1991,  1992;  Madara et al.,  1993).  T~ 
epithelial  monolayers were  exposed to  recombinant human IFN-3'  (106 
U/mi, Genentech, Inc.,  San Francisco, CA) for periods of time ranging 
from 2 to 72 h and at doses ranging from 1 to 1,000 U/ml. All incubation 
periods with IFN-3' included controls consisting of media containing no 
IFN -3'. 
Transmigration Assay 
The  PMN  transepithelial migration assay  has been  previously detailed 
(Nash et al., 1987, 1988;  Parkos et al.,  1991, 1992).  Briefly, human PMN 
were isolated from normal human volunteers and suspended in modified 
HBSS (without Ca  2+ and Mg  2+, with 10 mM Hepes, pH 7.4, Sigma Chem. 
Co.)  at  a  concentration of 5  x  107  mi.  Before addition of PMN,  Ts4 
monolayers were extensively rinsed in HBSS to remove residual serum 
components and IFN-3'. Transmigration assays were performed by the addi- 
tion of PMN to the upper chambers after chemoattractant (1 #M n-formyl- 
methionyl-leucyl-phenylalanine  [FMLP])  was  added  to  the  opposing 
(lower) chambers. For apical-to-basolateral transmigration experiments, 2 
x  106 PMN were added at time 0.  However, we have previously shown 
that transmigration in the basolateral-to-apical direction,  while qualita- 
tively similar, is substantially more efficient  than in the apical-to-basolateral 
direction (Parkos et al., 1991). Therefore, fivefold fewer PMN (4 x  105), 
unless otherwise noted, were added when transmigration proceeded in the 
basolateral-to-apical direction in order that baseline transmigration signals 
be equivalent in both directions (Parkos  et al.,  1991).  To  assess trans- 
epithelial resistance, the upper and lower reservoirs were interfaced with 
pairs of calomel and Ag-AgC1 electrodes via 5% agar bridges. Resistance 
measurements were obtained before and at 5, 10, 30, 50, and 110 min after 
the addition of PMN using a dual voltage clamp (University of Iowa) as de- 
scribed before. Validation of and techniques to apply such standard electri- 
cal techniques on such monolayer ~mini-preps" have been detailed else- 
where (Madara et al.,  1993). 
Divalent cation depletion experiments were performed as follows: epi- 
thelial monolayers were rinsed extensively in HBSS to remove residual se- 
rum and IFN-3,.  Monolayers were next rinsed free of HBSS and exposed 
apically and basolaterally to  1 mM EDTA (Sigma Chem. Co.) diluted in 
modified HBSS for 20 rain at 37~  After 20 rain, monolayers were repleted 
with Ca  2+ and Mg  2+ by rinsing and submerging in Ca  2+ and Mg  2+ contain- 
ing HBSS. PMN were added within 15 rain after the repletion of Ca  2+ and 
Mg  2+. 
Cycloheximide (Sigma Chem. Co.), when used, was prepared fresh as 
a 2-mg/ml stock in 95 % ethanol and diluted to 2/~g/ml in media at a concen- 
tration which we have previously found to inhibit >85 % of radiolabeled leu- 
cine incorporation into precipitable protein.  All experiments were per- 
formed in a  37~  room to ensure that epithelial monolayers, solutions, 
plasticware, etc., were maintained at uniform 37~  temperature. 
Transmigration was quantitated by assaying for the PMN azurophilic 
granule marker myeloperoxidase as described previously (Parkos et al., 
1991,  1992).  After each transmigration assay,  nonadherent PMN were ex- 
tensively washed from the surface of the monolayer and PMN cell equiva- 
lents, estimated from a daily standard curve, were assessed as the number 
of PMN associated with the monolayer, the number which had completely 
traversed the monolayer (i.e., into the reservoir bath), as well as the total 
number of transmigrating PMN  (the  sum of monolayer and  reservoir- 
associated PMN).  As we have previously described (Nash et al.,  1987; 
Parkos et al., 1991), the location of monolayer-associated PMN (apical vs. 
within paracellular space vs. attached to filter supports) was judged mor- 
phologically. 
Morphologic Studies 
Monolayers were fixed in 2 % glutaraldehyde in HBSS at the end of repre- 
sentative experiments (t =  120 min) and processed for 1 #M Epoxy sections 
or stained for the localization of peroxidase as described previously (Nash 
et al.,  1987). 
ICAM-1 ELISA 
Expression of ICAM-1 was assayed exactly as described by others (Rothlein 
et al., 1988) using RR1/1 (mouse ascites diluted 1:100 in 1% BSA) as a pri- 
mary antibody on 1% paraformaldehyde-fixed T84 epithelial monolayers in 
96-well flat-bottomed rnicrotiter plates (Costar Corp.). Negative controls 
included omitting the primary and/or secondary antibody. HL-60 cells were 
plated in triplicate on each plate, exposed to 10 ng/ml PMA for 3 d, and 
served as a positive control for ICAM-1  expression (Dustin et al.,  1986). 
PMN-Endothelial Adhesion Assay 
Adherence of purified human PMN to confluent monolayers of human um- 
bilical vein endothelial cells (a kind gift from Dr. Michael Gimbrone) was 
done as described previously (Charo et al., 1985) with minor modifications. 
After the final wash, 100/zl ABTS  solution (containing 1 mM 2,2'-azino- 
di-[3-ethyl] dithiazoline sulfonic acid with 10 mM H202 in 100 mM citrate 
buffer, pH 4.2) was added to each well and color development was assayed 
at 405 nM on a microtiter plate reader (Bio-Rad Laboratories, Richmond, 
CA). When used, mAb R6.5  Fab (50 #g/mi) was preincubated with en- 
dothelial cells for 30 min at 25~  before addition of PMN. 
Data Presentation 
Since variations exist in both transepithelial resistance between groups of 
monolayers (baseline resistance range 650-1,500 ohm.cm2) and in PMN 
obtained  from different donors,  individual experiments were performed 
using large numbers of uniform groups of monolayers and PMN from single 
blood donors on individual days. PMN isolation was restricted to 12 differ- 
ent donors (repetitive donations) over the course of  these studies. To account 
for monolayer-to-monolayer resistance differences within experiments, re- 
sistance data were normalized and expressed as percent baseline resistance, 
unless otherwise noted. Resistance time courses were compared by two- 
factor analysis of variance (ANOVA) and myeloperoxidase assay data were 
compared by Student's t test (Steele and Torrie, 1980).  PMN transmigration 
results are represented as PMN cell equivalents (CE) derived from a daily 
standard PMN dilution curve. Monolayer-associated PMN are represented 
as the number of PMN CE per monolayer and reservoir-associated PMN 
(i.e., PMN which had completely traversed the monolayer into the lower 
chamber) are represented as the number of PMN CE/ml (total volume of 
1 ml). Values are expressed as the mean and SEM of n experiments, 
Results 
IFN-y Modulates PMN Migration in the 
Apical-to-Basolateral Direction 
IFN-~  Upregulates Apical-to-Basolateral  PMN Transmi- 
gration.  As  shown  in  Fig.  1,  exposure  of T~  epithelial 
monolayers  to  1,000  U/ml IFN--y  for 72  h  results  in sig- 
nificantly  increased  PMN  transepithelial  migration  in the 
presence of a 1-/~M FMLP gradient.  Pretreatment  of epithe- 
lial  monolayers  with  IFN-3,  increased  both  monolayer- 
associated PMN CE (3.7  +  0.87  x  104 for controls vs.  12.2 
+  1.31  ￿  104  PMN  CE/monolayer  for  IFN-y-treated 
monolayers, p  <  0.001,  transmigration  time  =  110 rain) as 
well as the number of PMN traversing the monolayer into the 
reservoir (8.2  +  1.53  vs.  19.7 +  2.07  ￿  104 PMN CE/ml 
for control and IFN-3,-treated monolayers, respectively, p < 
0.001).  To  further  characterize  this  transmigratory  event, 
T~ epithelial monolayers were exposed to IFN-3,  for vari- 
ous time periods in the range of 2 to 72 h. As shown in Fig. 
2  A,  treatment  of T84 monolayers  with  1,000  U/ml IFN--y 
Colgan  et al.  Regulation of Neutrophil Transepithelial Migration by IFN-  y  787 Figure I. Effect of epithelial exposure to IFN-3, (1,000 U/ml, 72 h) 
on the number of PMN transmigrating in the apical-to-basolateral 
direction.  PMN at a density of 2  x  106/monolayer were added to 
the apical surface of T~ intestinal epithelial monolayers and driven 
to migrate basolaterally under the influence of a 1-/zM gradient of 
FLMP.  Shown here are the results obtained  from harvesting the 
PMN-specific enzyme myeloperoxidase from washed monolayers, 
lower reservoirs and total myeloperoxidase activity after 110 min, 
relative to a known standard number of PMN. Since tight junctions 
are the  rate-limiting  barrier to passive paracellular  permeation, 
transmigration  is defined as movement of PMN across the tight 
junction.  Since monolayer-associated PMN were largely below the 
tight junction  (see Results), total transmigration  in the apical-to- 
basolateral direction equals the sum of PMN in the opposite reser- 
voir plus monolayer PMN.  Data are pooled from nine individual 
monolayers in each condition and results are expressed as the mean 
and SEM. 
for various periods of time enhanced the usual transmigra- 
tion-associated fall in transepithelial resistance (p <  0.01 vs. 
control at 12,  24, 48, and 72 h, respectively), indicative of 
PMN  impalement of the  %,  tight junction  (Nash  et  al., 
1987).  However, we have previously shown that prolonged 
exposure of monolayers to IFN-3, also decreases baseline 
monolayer resistance (Madara and Stafford,  1989) and the 
same effect was noted here (344  +  70, 461  +  20, and 721 
+  27 ohm-cm  2 for exposure times of 72,  48,  and 0  h,  re- 
spectively, to  1,000  U/ml IFN-7).  However, the effects of 
IFN-3, on PMN transepithelial migration were not explained 
by a secondary effect of IFN-'y permeability since the effects 
on transmigration predated IFN--r resistance alterations. As 
shown  in  Fig.  2  B,  and  as  we  have previously described 
(Madara  and  Stafford,  1989),  baseline  resistance  is  un- 
affected by monolayer exposure to  1,000  U/ml IFN-'y for 
24 h (721  +  27 vs. 715  +  42 ohm.cm  2 for control and 24-h 
IFN--r exposure, respectively, p  >  0.05). In contrast (Fig. 2 
B),  the  transepithelial  resistance  fall due  to  PMN  trans- 
migration (a biological assay which correlates with numbers 
of transmigration PMN [Nash et al.,  1987;  Parkos et al., 
1991]) was significantly enhanced across monolayers which 
were exposed to 1,000  U/ml IFN-3, for 24 h (60  5: 5% fall 
in resistance after 2 h in control vs. 76  +  2% fall in resis- 
tance for IFN-3,-treated monolayers, p < 0.01). Correspond- 
ing to these data, as shown in Fig. 2 C, the number of trans- 
migrated  neutrophils,  directly  assessed  quantitatively  by 
myeloperoxidase, was greater even after a 24-h preexposure 
of monolayers to IFN-'r (p <  0.001, ANOVA). Fig. 2 C also 
confirms that the effects observed were not due to carryover 
of IFN-3, from preexposed and subsequently washed mono- 
layers. As can be seen, transmigration is identical between 
monolayers unexposed to IFN-7 and monolayers incubated 
with IFN-3, for 2 h, washed, and then exposed to PMN. Such 
observations are important given that IFN-7 may be able to 
bind to some basement membrane components with high 
affinity (Lortat-Jacob et al.,  1991).  These, and supplemen- 
tary data (vida infra), indicate the effects observed are due 
exclusively to IFN-'y-mediated modulation of monolayers, 
not  neutrophils.  The  IFN-~/  exposure/time-dependent  en- 
hancement  of  subsequent  neutrophil  transmigration  was 
Figure 2. Effect of epithelial exposure to IFN-gr and PMN transmigration  in the apical-to-basolateral  direction.  PMN were added to the 
apical surface of T~ intestinal epithelial monolayers and driven to transmigrate  basolaterally  under the influence of a 1-#M gradient of 
FMLP. Shown here are (A) the normalized (expressed as % of  baseline) results of the fall in transepithelial resistance during transmigration 
across epithelial monolayers preexposed to IFN-'y (1,000 U/ml) for various periods of  time in the range of 12-72 h. Also shown is the negative 
control  (no PMN added at time 0),  (B) comparison  of the true resistance  time course  of resistance  fall after addition of PMN to the 
basolateral side of control monolayers and monolayers preexposed to IFN-'r (1,000 U/ml, 24 h), (C) quantitation of the number of trans- 
migrating PMN across monolayers which were preexposed to IFN-3' (1,000 U/ml) for a variety of time periods  in the range of 2-72 h. 
Results are presented  as the mean and SEM of between 6 and  10 monolayers each. 
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of IFN-~ on the number of PMN transmigrating in the apical-to- 
basolateral direction. T~ intestinal epithelial monolayers were ex- 
posed  to five different concentrations of IFN-~  in the  range of 
1-1,000 U/rnl for 72 h. PMN were added to the apical surface of 
Ts4 intestinal epithelial monolayers and driven to migrate baso- 
laterally under the influence of a 1-#M gradient of FMLP. Shown 
here are the results obtained from harvesting the PMN-specific en- 
zyme myeloperoxidase from washed monolayers, lower reservoirs 
and  total myeloperoxidase activity after  110 min,  relative to a 
known standard number of PMN.  Data are pooled from 6-9 in- 
dividual monolayers for each condition and results are expressed 
as the mean and SEM. 
largely due to transmigrated PMN (11.5  +  1.80 vs. 37.7  + 
2.36 PMN CE/ml for control and IFN-exposed monolayers 
at 72 h, respectively, p  <  0.001), although, not surprisingly, 
a  significant  enhancement  of the  number  of monolayer- 
associated PMN was also found (2.76  +  0.57  x  104 PMN 
for controls vs. 4.11  +  0.56 x  104 PMN CE/monolayer for 
monolayers exposed to 1,000 U/ml IFN--y for 72 h, p < 0.01). 
No  significant  increase  in  the  number  of transmigrating 
PMN were found at 2, 4,  or 12 h of exposure (Fig. 2  C). 
The dose response to 72 h of monolayer preexposure to 
IFN-3, is shown in Fig. 3. Exposure of epithelial monolayers 
to I-1,000 U IFN-3,/ml elicited a progressive increase in the 
number of transmigrating PMN.  IFN-3,-induced increases 
in PMN transmigration were again largely reflective of in- 
creased numbers of neutrophils moving to the opposite res- 
ervoir although a  small  increase in transiting  PMN  (i.e., 
monolayer associated) was again seen.  As reported previ- 
ously (Parkos et al., 1991), examination of 1-#m Tu epithe- 
lial monolayer sections revealed that PMN were only rarely 
associated with the apical epithelial surface (data not shown). 
Rather,  the  majority  of monolayer-associated PMN  were 
found associated  with  basal  or lateral  membranes  of T84 
cells. Therefore, monolayer-associated PMN in this apical- 
to-basolateral assay had transmigrated across the tight junc- 
tion barrier. 
We  next examined the  effect of IFN-~,  upregulation of 
PMN transepithelial migration as a function of  applied PMN 
number. PMN were applied over an eightfold range in den- 
sity to monolayers preexposed to IFN-3, (1,000 U/ml, 72 h). 
AS shown in Fig. 4, an increase in the total number of trans- 
migrating PMN after epithelial exposure to IFN-3, was main- 
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Figure 4. Effect of PMN density on the number of transmigrating 
PMN in the apical-to-basolateral direction. PMN at the indicated 
concentrations were layered on control Tu epithelial monolayers 
and on monolayers which were preexposed to IFN-  3, (1,000 U/ml, 
72 h). Shown here are the total PMN number (the sum of mono- 
layer and reservoir-associated PMN) migrating in response to a 
1-/~M FMLP gradient after 110 min. Data were pooled from six 
monolayers each and are presented as the mean and SEM. 
0.001;  1  ￿  10 ~, p  <  0.001; 0.5  ￿  10% p  <  0.001; and 0.25 
x  104 PMN/monolayer, p  <  0.01). 
To determine whether the basal secretion of a chemotactic 
substance could account for increased transmigration in the 
apical-to-basolateral direction, PMN were placed on the api- 
cal surface of  control (monolayers not exposed to IFN-'y) and 
IFN-3, preexposed (1,000 U/ml, 72 h) T84 epithelial mono- 
layers in the absence of an FMLP gradient and allowed to 
incubate for 2  h  at 37~  Under these conditions, no ob- 
served increase in total PMN transmigration was evident 
(2.1  +  0.09 vs.  2.3  +  0.18  x  104 for control and IFN- 
"y-exposed monolayers, respectively; n  =  6, p > 0.05), indi- 
cating that IFN-'y pretreatment does not induce the secretion 
of a  chemotactic factor potent enough to induce transepi- 
thelial migration of PMN. 
As detailed above, IFN-3,-elicited upregulation of PMN 
migration across epithelial monolayers was apparent at 24 h 
-a time at which baseline resistance was unaffected by IFN--y. 
We further verified that enhanced transmigration was  not 
wholly dependent on subtle baseline or evolving effects on 
junctional permeability induced by this cytokine. To do this, 
PMN transmigration was examined using IFN-'/-exposed 
(1,000 U/ml, 72 h) and -unexposed monolayers in which the 
junctional barrier had been disrupted by exposure of epithe- 
lial monolayers to  1 mM  EDTA in  CaWMg2§  buffer 
for 20 min.  As in other cultured epithelia (Pitelka et al., 
1983),  treatment of Tu epithelial monolayers with  1 mM 
EDTA induces a disruption of tight junctions and a fall in re- 
sistance to near background levels. Using the conditions out- 
lined, we found we could return monolayers to physiologic 
buffers with a  subsequent resistance recovery to pretreat- 
ment values over 2 h (data not shown). Thus, we were able 
to  isolate  IFN-~  effects on  transmigration  from  general 
effects on junctional permeability. Divalent cation depletion 
brought about a significant increase in the number of trans- 
migrating PMN across control monolayers (17.1 +  1.31 vs. 
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Figure 5. Effect of PMN antiintegrin antibodies on the number of 
PMN transmigrating in the apical-to-basolateral direction. PMN 
were incubated with the indicated antiintegrin antibodies at saturat- 
ing concentrations, previously determined to be functionally in- 
hibitory (see Materials and Methods), and layered on control epi- 
thelial monolayers or on monolayers which were exposed to IFN-~/ 
(1,000 U/ml, 72 h). Also shown is the PMN binding control (mAb 
J5, see Materials and Methods) and the control in the absence of 
antibody. Data were pooled from between 6 and 9 monolayers for 
each condition and presented as the mean and SEM. 
9.6  +  0.11 PMN CE/ml with and without EDTA pretreat- 
ment, respectively; p < 0.001) and across monolayers preex- 
posed to IFN-'y (26.4  +  2.95 vs. 21.7  5:1.83 PMN CE/ml 
with  and  without  EDTA  pretreatment,  respectively; p  < 
0.025).  Under  conditions  of  EDTA  pretreatment,  the 
significant enhancement of PMN transmigration induced by 
preexposure of monolayers to IFN-3, was still clearly appar- 
ent (17.1  +  1.31 vs.  26.4  +  2.95 PMN CE/ml for controls 
and IFN-,r-exposed monolayers, respectively; p  <  0.025). 
These results were obtained from a condition in which the 
junctional permeability barrier was  near maximally abol- 
ished.  This  evidence,  in  conjunction with  the  IFN-3,  en- 
hancement of transmigration seen at 24 h and other evidence 
summarized  in  the  second  paragraph  of the  discussion, 
strongly suggests  that the observed upregulation of trans- 
migration  induced  by  IFN-3,  in  the  apical-to-basolateral 
direction is independent of junctional permeability changes 
brought about by this cytokine. 
IFN-~-induced  Upregulation of Apical-To-Basolateral 
Transmigration is CD11b/CD18 Dependent.  As shown pre- 
viously (Parkos et al.,  1991),  PMN migration across cyto- 
kine  untreated  monolayers is  dependent on the  PMN  /32 
integrin CDllb/CD18.  To investigate  whether IFN-3,-upreg- 
ulated PMN transmigration also involves a pathway depen- 
dent  on  the  t2  integrins,  epithelial  monolayers  were  ex- 
posed  to  IFN-'y  (1,000  U/ml,  72  h)  and  subsequently 
assessed for PMN transmigration in the presence of func- 
tionally inhibitory concentrations of fl2-integrin  monoclo- 
nal antibodies. As shown in Fig. 5, the presence of function- 
ally inhibitory concentrations of mAbs to CD1 lb and CD18 
inhibited  the  number  of transmigrating  PMN  by  95  + 
2 % and 96 5:7 %, respectively, in control monolayers. More- 
over, in epithelial monolayers preexposed to IFN-~ (1,000 
U/ml, 72 h), anti-CD18 and anti-CD1 lb mAbs inhibited this 
PMN  transmigratory event by 84  5:  7%  and  93  +  6%, 
Figure 6. Effect of epithelial exposure to IFN-,y (1,000 U/ml, 72 h) 
on the number of PMN transmigrating in the basolateral-to-apical 
direction. PMN at a density of 4  x  105/monolayer  were added to 
the basolateral surface of Tu intestinal epithelial monolayers (i.e. 
inverted monolayers) and driven  to migrate  apically  under  the 
influence of a 1-/zM gradient of FMLP. Shown here are the results 
obtained from harvesting the PMN-specific enzyme myeloperoxi- 
dase from lower reservoirs (.4)  and washed monolayers (B) after 110 
min,  relative to a known standard number of PMN.  Since tight 
junctions  are  the  rate-limiting  barrier  to  passive  paracellular 
permeation, transmigration is defined as movement of PMN across 
the tight junction. Since monolayer-associated PMN were largely 
below the tight junction (see Results), total transmigration in the 
basolateral-to-apical direction equates with PMN in the opposite 
reservoir only. Data are pooled from 6-9 individual monolayers in 
each condition and results are expressed as the mean and SEM. 
respectively.  Transmigration in  the  presence of mAbs  to 
CD10 05, PMN binding control), CD1 la, or CD1 lc were not 
different from control  in  monolayers untreated  or preex- 
posed to IFN-~ (p > 0.05). These data indicate that increased 
PMN transmigration  in the apical-to-basolateral direction 
elicited by epithelial exposure to IFN-'y also largely involves 
a  pathway  which  is  dependent  on  the  PMN  /~2-integrin 
CD1 lb/CD18. 
IFN'7 Effects on PMN Transmigration  in the 
Basolateral-to-Apical  Direction 
IFN-~/ Downregulates PMN Transmigration in the Baso- 
lateral-to-Apical Direction.  We  have previously detected 
quantitative, but not qualitative, differences in PMN trans- 
epithelial migration depending on the direction of migration. 
We  next  prepared  inverted  monolayers,  which  permit 
basolateral-to-apical  directed  transmigration,  to  assess 
whether IFN-'y pretreatment of epithelial  monolayers ex- 
hibited polarized effects on subsequent  PMN  transmigra- 
tion. As shown in Fig. 6, exposure of monolayers to IFN-7 
(1,000 U/ml, 72 h) also markedly altered PMN transmigra- 
tion in the basolateral-to-apical direction, but surprisingly 
did so in a fashion which differed qualitatively from the re- 
sult in the apical-to-basolateral direction. Transmigration of 
PMN in this direction was significantly decreased compared 
to untreated control epithelial monolayers (11.8 +  0.46 vs. 
1.46  +  0.68  PMN/ml  for  control  and  IFN-3,-treated 
monolayers, respectively;  p < 0.001, Fig. 6 A). Furthermore, 
pretreatment of epithelial monolayers with IFN--y induced 
more than a  100%  increase in monolayer-associated PMN 
(2.54 + 0.15 vs. 5.79 + 0.76 PMN/monolayer for control and 
IFN-3,-treated monolayers, respectively;  p < 0.05, Fig. 6 B). 
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migration in the basolateral-to-apicai direction. PMN were added 
to the basolateral  surface of T84 intestinal epithelial monolayers 
and driven to transmigrate apically under the influence of the I-#M 
gradient of FMLP. Shown here is quantitation of the number of 
transmigrating PMN across monolayers which were preexposed to 
IFN-3, (1,000 U/ml) for a variety of time periods in the range of 
24-72 h. PMN migration was determined by assaying for reservoir 
(,4) and monolayer-associated myeloperoxidase (B) against a stan- 
dard number of PMN. Results are presented as the mean and SEM 
of between 6 and 9 monolayers per condition. 
Examination of 1-/~m sections of such monolayers again re- 
vealed that monolayer-associated PMN were uniformly as- 
sociated with the basolateral space of the monolayer (not the 
apical surface of  the monolayer or the filter support; data not 
shown). 
A time course of IFN--/exposure (1,000 U/ml) was next 
performed for basolateral-to-apical directed migration (Fig. 
7). A progressive decrease in the number of transmigrating 
PMN resulted with increasing periods of exposure to IFN-,y 
(Fig. 7 A, p < 0.001, ANOVA).  In contrast, as shown in Fig. 
7  B,  IFN-3,  treatment  elicited  a  significant  increase  in 
monolayer-associated PMN with increasing time of epithe- 
lial exposure to IFN-3, (2.05  +  0.06,  2.69  +  0.18, 4.19  + 
0.67, and 5.64  +  1.16 PMN/monolayer, for exposure times 
of 0,  24,  48,  and 72 h,  respectively; p  <  0.025  for 48 and 
72 h). Comparable results were obtained from dose-response 
experiments (all 72 h preexposure, Fig. 8). Increasing con- 
centrations of IFN-3, resulted in a progressive decrease in 
transmigrated PMN (Fig. 8 A). Again, this diminished trans- 
migratory response in the basolateral-to-apical direction was 
accompanied by an increase in monolayer-associated PMN 
(Fig.  8 B, p  <  0.001 and p  <  0.025,  respectively, for trans- 
migrated  and  monolayer-associated PMN  numbers,  both 
ANOVA). 
To determine whether the kinetics of PMN migration in 
the basolateral-to-apical direction differed after epithelial 
exposure to IFN-%  monolayers were harvested at various 
time points during transmigration and assayed for PMN by 
myeloperoxidase content. As shown in Fig. 9 A, the number 
of transmigrating  PMN  increased with  increasing experi- 
mental time across both control monolayers and monolayers 
which were preexposed to IFN-3, (ANOVA, p < 0.01 for con- 
trois and p  <  0.05 for IFN-3, preexposed monolayers). As 
depicted  in  Fig.  9  A,  decreased  PMN  migration  across 
monolayers preexposed to IFN-3, was apparent by 60 min 
(p < 0.01) and progressively decreased at 85 (p <  0.001) and 
120 min  (p <  0.001).  As  shown in  Fig.  9  B,  monolayer- 
associated PMN did not change over the 2-h experimental 
period in either control or IFN-'y preexposed monolayers 
(ANOVA,  p  >  0.05  for  both).  Compared  with  control 
monolayers,  increased  PMN  association  to  monolayers 
preexposed to IFN-3, was  apparent at all time periods of 
monolayer harvest (p <  0.01 for all time periods). 
As depicted in Fig. 9 C, after epithelial exposure to 1,000 
U/ml  IFN-3,,  a  decrease in  the number of transmigrating 
PMN  in  the  basolateral-to-apical  direction  was  apparent 
over a 20-fold range in initial PMN concentrations (ANOVA, 
p < 0.01). Moreover, a greater number of monolayer-associ- 
ated PMN were apparent in monolayers preexposed to IFN-3, 
(Fig. 9 D, ANOVA, p  <  0.05). These data indicate that de- 
creased  PMN  transmigration  in  the  basotateral-to-apical 
direction after epithelial IFN-  3, exposure is independent of 
initial PMN concentrations and is apparent at various time 
periods during the course of the experiment. 
Morphoiogic Correlates of PMN Transmigration in the 
Basolateral-to-Apical Direction.  We were able to morpho- 
logically demonstrate increased accumulation of monolayer- 
associated PMN after epithelial exposure to IFN-3, (Fig. 10). 
PMN were highlighted by localizing PMN endogenous per- 
layers (B) after 110 min against a known standard number of PMN. Data are pooled from 6-9 individual 
and results are expressed as the mean and SEM. 
Figure 8.  Effect of epithelial 
exposure to different concen- 
trations of IFN-~, on the num- 
ber of PMN transmigrating in 
the basolateral4o-apical direc- 
tion.  Ts4 intestinal epithelial 
monolayers were exposed to 
four different concentrations 
of  IFN-~ in the range  of 1-1~00 
U/nil  for 72  h.  PMN  were 
added to the basolateral sur- 
face of T~ intestinal epithe- 
lial monolayers and driven to 
migrate apically under the in- 
fluence of a I-~M gradient of 
FMLP.  Shown here are the 
results obtained from harvest- 
ing the PMN-specific enzyme 
myeloperoxidase from lower 
reservoirs  (A) and washed  mono- 
monolayers for each condition 
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Figure  9.  Effect of time  of 
monolayer harvest and applied 
PMN density on the number 
of transmigrating PMN in the 
basolateral-to-apical direction. 
(A and B) PMN at the indi- 
cated concentrations were lay- 
ered on control Tu epithelial 
monolayers and on monolayers 
which  were  preexposed  to 
IFN-y  (1,000 U/ml,  72  h). 
Shown here are the number of 
PMN migrating into the reser- 
voir (A)  and  the  number  of 
monolayer-associated  PMN 
(B)  in  response  to  a  1-#M 
transepithelial FMLP gradient 
after 110 min. (Cand D) Con- 
trol  monolayers and  mono- 
layers  preexposed  to  IFN-y 
(1,000 U/ml) were harvested 
at the indicated time periods 
during the transmigration as- 
say. Shown here are the num- 
ber  of PMN  migrating  into 
the reservoir at each indicated 
time period (C) and the num- 
ber  of monolayer-associated 
PMN at each time period (D) 
in response to a  1-#M trans- 
epithelial FMLP gradient after 
110 min.  Data  were pooled 
from six monolayers each and 
are presented as the mean and 
SEM. 
oxidases in en face-stained monolayers (Nash et as.,  1987) 
1 h after the addition of PMN under chemotactic conditions 
(4  x  10  ~ PMN added to the basolateral aspect of mono- 
layers and driven to transmigrate by a  10  -6 M  gradient of 
FMLP). The density of PMN was dramatically increased in 
monolayers which were preexposed to IFN-7 (Fig.  10 C) 
compared with control monolayers (Fig. I0 A). These results 
correlate with the enzymatic accumulation of myeloperoxi- 
dase after epithelial exposure to IFN-y (vide supra). 
l-#m sections of monolayers from transmigration experi- 
ments in the serosal-to-mucosal direction showed increased 
accumulation of  PMN in monolayers which were preexposed 
to IFN-  7  (Fig.  10 D) compared with control T84 epithelial 
monolayers (Fig.  10 C).  PMN associated with Tu mono- 
layers/filters were largely monolayer associated. 
Effect of Antibodies  to PMN /3rlntegrins  on  IFN-y 
Modulation in the Basolateral-to-Apical Direction. To de- 
termine  whether  decreased  PMN  transmigration  in  the 
basolateral-to-apical direction after IFN-3, exposure could 
be further influenced by mAbs to PMN ~2-integrins, trans- 
migration across inverted monolayers was assessed in the 
presence of functionally inhibitory concentrations  of/~2- 
integrin mAbs, as described above. As shown in Fig.  11 A, 
the presence of anti-CD18 and anti-CD1 lb mAbs decreased 
PMN transmigration by 85  5= 4%  and 90  +  5%, respec- 
tively, compared with the PMN binding control 05) across 
control epithelial monolayers, and by 51  +  3 % and 53  5= 
6%,  respectively, across epithelial monolayers which had 
been preexposed to IFN-3, (1,000 U/ml, 72 h). The number 
of monolayer-associated PMN tended to decrease in control 
monolayers in the presence of anti-CD18 (p < 0.01) and anti- 
CDllb mAbs (p <  0.05)  (Fig.  11 B). The presence of anti- 
CD18 and anti-CDllb mAbs had no effect on the number of 
PMN associated with monotayers preexposed to IFN-3,. The 
presence of mAbs to CD1 la and CD1 lc during transmigra- 
tion  did  not  significantly decrease  the  number  of trans- 
migrating  PMN  or  the  number  of monolayer-associated 
PMN.  These  results  indicate  that  the  PMN  /32-integrin 
CDllb/CD18  is  a  necessary  component for  PMN  trans- 
migration across IFN-y-treated epithelial monolayers. 
Effect of Cycloheximide on the Modulation of PMN 
Transepithelial  Migration by IFN~ 
To determine whether the effects of IFN-"/on PMN trans- 
migration required the synthesis of new protein by epithelial 
cells,  transmigration  was  assessed  in  both the  apical-to- 
basolateral and the basolateral-to-apical directions after ex- 
posure of epithelial cells to IFN-3, (1,000 U/ml, 72 h) in the 
presence and absence of  2 #g/ml cycloheximide. In perform- 
ing these experiments, and as shown in Fig.  12 A, we found 
that monolayers were able to maintain baseline electrical 
characteristics, such as high transepithelial resistance, even 
after a 72-h exposure to cycloheximide (1,148  +  63 ohm. 
cm  2 vs.  1,184  +  81  ohm.cm  2 for  cycloheximide-treated 
control monolayers, p  > 0.05). We also noted that, interest- 
ingly, the drop in transepithelial resistance after prolonged 
exposure to IFN-3, (1,000 U/ml, 72 h) which we have previ- 
ously described (Madara and Stafford, 1989), is largely cy- 
The Journal of Cell Biology, Volume 120,  1993  792 Figure 10. Epithelial preexposure to IFN-3, increases monolayer-associated  PMN after basolateral-to-apical directed transmigration. T~ 
epithelial monolayers  were exposed to IFN-3, (1,000 U/ml, 72 h) followed  by the addition of PMN to the basolateral side under chemotactic 
conditions (1  x  1@  PMN/monolayer, 10  -6 M FMLP gradient). A (control) and C (IFN-3, exposed) demonstrate en face views of 
monolayers obtained from a mid-epithelial plane of the monolayers (Nash et al.,  1987). PMN (arrows) are highlighted by peroxidase 
histochemistry and appear as discrete black cells. The open circles focally displaying  a "stacked coin" appearance represent the 5-/~m  pores 
in the polycarbonate filter. B (control) and D (IFN-3, exposed) demonstrate 1-/zm sections of Ts4 monolayers. The apical (,'lp) and 
basolateral (BL) reservoirs are marked as are the polycarbonate  filters (F). PMN display  characteristic lobated nuclei and can be morpholog- 
ically distinguished both within/above the monolayer (arrowhead) and below the filter (arrows). IFN-3, markedly enhances the number 
of monolayer associated PMN (A vs. C). The majority of monolayer/filter associated PMN after IFN-3, exposure are above, not below, 
the filter. At sites of transmigration of large numbers of PMN the monolayer is focally disrupted (D). Bars, ~10/zm. 
cloheximide sensitive (Fig. 12A). With basolateral-to-apical 
directed transmigration,  cycloheximide inhibited both the 
IFN--t-induced  downregulation  of  PMN  transepithelial 
migration and the upregulation of PMN migration into the 
monolayer (Fig.  12 B).  Finally, with apical-to-basolateral 
directed  PMN  migration,  upregulation  of transepithelial 
migration by IFN-~/was again inhibited (Fig.  12 C). These 
data suggest that new protein synthesis is, in part, necessary 
for the IFN-~ modulations of PMN transepithelial migration 
in either direction. 
Effects of  lFN-7 on PMN Transepithelial 
Migration Can Not Be Explained by IFN~ 
Modulation of  l CAM-1 
The expression of  ICAM-1 is known to be modulated in some 
cell  types  by  IFN-  7  and  other  inflammatory  cytokines 
(Dustin et al., 1986). Moreover, ICAM-1 is a putative recep- 
tor for CD1 lb/CD18 (Diamond et al., 1991), and this epitope 
is bound and functionally inhibited by the mAb R6.5 (Dia- 
mond et al.,  1991). To determine whether ICAM-1  regula- 
tion by IFN-3~ could explain the results found above,  we 
performed  apical-to-basolateral  and  basolateral-to-apical 
directed transmigration experiments in the presence of the 
anti-ICAM-1 mAb R6.5 (Fab fragments, 50/zg/ml) after epi- 
thelial exposure to IFN-3, (1,000 U/ml, 72 h). The presence 
of R6.5 during transmigration failed to significantly alter the 
pattern of PMN transmigration regulation by IFN--y in the 
basolateral-to-apical (total of 4.7  •  0.50  x  104 PMN CE 
transmigrated in the presence of R6.5 Fab while 5.4 +  0.61 
x  llY PMN CE transmigrated in the absence of R6.5 Fab, 
n = 4 each, NS) or in the apical-to-basolateral direction (to- 
tal of 20.4  +  2.36  x  104 PMN CE transmigrated in the 
presence of R6.5  Fab while 19.5 +  1.16  x  104 PMN CE 
transmigrated in the absence of R6.5 Fab, n  =  6 each, NS). 
As a positive control for the anti-ICAM-1 mAb, PMN adhe- 
sion to endothelial monolayers was assessed in the presence 
and absence of R6.5 Fab (50 #g/ml). In these experiments, 
R6.5  Fab  blocked  the  adhesion  of PMN  to  endothelial 
monolayers by 72%  (23.7  +  2.83  x  104 PMN CE/mono- 
layer bound for controls and 6.71 +  1.85 x  104 PMN CE in 
the presence of R6.5 Fab, p  <  0.001). 
These results correlate with our conclusion that IFN-~ 
does not significantly modulate apical ICAM-1 expression at 
times in which apical-to-basolateral directed transmigration 
was affected, as determined by ELISA on adherent Tu epi- 
thelial cells. Tu epithelial cells preexposed to  1,000  U/ml 
IFN-'y did not show significantly increased ICAM-1 expres- 
sion (mean OD 0.51  +  0.088, 0.53  +  0.085, 0.61  +  0.071 
at 72, 48,  and 24 h IFN--y, exposure, respectively, n  =  6) 
compared with control monolayers (mean OD 0.49 +  0.063 
n  =  6). In contrast, ICAM-1 expression by adherent HL-60 
cells was readily measured in this assay (mean OD  1.05 • 
0.065, n  =  6). Moreover, preexposure of human endothelial 
monolayers to IFN-~ (500 U/ml, 48 h) resulted in a 260  • 
39 % increase in OD (n =  6, p < 0.001) under the conditions 
used here. 
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Figure 11. Effect of PMN anti- 
integrin antibodies on the num- 
ber of PMN transmigrating in 
the  basolateral-to-apical  di- 
rection.  PMN  were  prein- 
B  cubated  with  the  indicated 
4]  MONOLAYER  antiintegrin  antibodies  at 
saturating concentrations pre- 
viously  determined  to  be 
functionally  inhibitory  (see 
3  Materials and Methods),  and 
layered  on  control  epithelial 
monolayers or on monolayers 
~  .lFwy  were exposed  IFN-3,  which  to 
-IFN~  2  (1h00 U/ml, 72 h). Also shown 
is  the  PMN  binding  control 
(J5,  see  Materials  and 
~o  Methods) and the no-antibody 
control.  The results  are pre- 
sented as the number of PMN 
migrating  into  the  reservoir 
~  ~  o  |  (A) and the number of mono- 
,~  ~"  ~  ~,~  ~  oB  layer-associated  PMN  (B). 
o  ,~  o  o  o  ~  Data  were  pooled  from  six 
m  o  monolayers for each condition 
o  ~  and presented as the mean and 
o  SEM. 
Discussion 
We report two general and major new findings. First, to our 
knowledge  this  is  the  first detailed  report  showing  that  a 
cytokine can modulate PMN transmigration across confluent 
epithelial monolayers. Second, we report for the first time a 
condition  (IFN-~/exposure)  which  elicits  effects on  PMN 
transmigration  that  qualitatively  differ  depending  on  the 
direction  of migration. 
IFN-'y Modulates PMN Transepithelial  Migration  in 
the Apical-to-Basolateral Direction 
Studies  of PMN  transepithelial  migration  have largely  fo- 
cused on this nonphysiologically directed migration for tech- 
nical reasons (Evans et al.,  1983; Cramer et al., 1986; Milks 
et  al.,  1986;  Nash  et  al.,  1987;  Migliorisi  et  al.,  1988; 
Parkos et al.,  1991).  However, we have also recently shown 
that,  while  the  efficiency of transmigration  does  vary de- 
pending on the direction in which PMN cross monolayers, 
in several qualitative ways transmigration is similar in both 
directions (i.e., ability of transmigration to proceed, specific 
chemotactic gradients required,  and CDllb/18 dependence) 
(Parkos  et  al.,  1991).  Using  this  apical-to-basolateral  di- 
rected  transmigration  assay  as  a  screening  procedure,  we 
find that the cytokine IFN-'y, which is richly expressed in the 
intestinal  mucosa of humans  (Quiding  et al.,  1991),  exerts 
major  effects on  transepithelial  migration.  Namely,  trans- 
epithelial migration of PMN in this direction is markedly up- 
Figure 12. Effect of cycloheximide on IFN-3, modulation of PMN transmigration. T~ intestinal epithelial monolayers were incubated in 
the presence or absence of 2/~g/ml cycloheximide and in the presence or absence IFN-3, (1,000 U/ml, 72 h) to determine what effect inhibi- 
tion of new protein synthesis has on IFN--y modulation of PMN transmigration. Shown here are the true baseline resistances (,4), results 
from the myeloperoxidase assay in the basolateral-to-apical direction (B),  and in the apical-to-basolateral direction (C). No differences 
existed in the number of transmigrating PMN between controls treated and untreated with cycloheximide. Data were pooled from six 
monolayers in each condition and presented as the mean and SEM. 
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Furthermore, such upregulation is apparent both throughout 
the time course of transmigration and with varying densities 
of applied PMN, and the degree to which the response is up- 
regulated varies as a function of dose and time of epithelial 
exposure to IFN-3,. Although we have previously shown that 
IFN-,y  decreases  tight junction  resistance  (Madara  and 
Stafford, 1989), it is unlikely that this decrease in resistance 
accounts for the observed enhancement of  transmigration for 
several  reasons.  First,  IFN--r-mediated  enhancement  of 
transmigration was still apparent after both control and IFN- 
y-treated monolayers were exposed, before transmigration, 
to  Ca2+-depleting  conditions which  open  tight junctions. 
Second, the IFN-'g-elicited enhancement of transmigration 
was  only  seen  with  apical-to-basolateral  directed  PMN 
migration.  Third,  the enhancement of transmigration oc- 
curred in monolayers exposed to IFN-'y for periods of time 
insufficient  to elicit alterations in baseline resistance. Lastly, 
even though gross perturbations of tight junctions, such as 
those elicited by Ca  2§ depletion, modestly enhanced trans- 
migration. Monolayers exposed to even 1,000 U/ml IFN-'y 
for 72 h maintain resistances generally exceeding 250-300 
ohm.cm  2 (Madara and Stafford, 1989),  and we have previ- 
ously shown that modulation of epithelial resistance in the 
range of 200-2,000  ohm.cm  2 has little effect on the effi- 
ciency of PMN transmigration (Nash et al., 1987).  This is 
likely due to the fact that the relationship between resistance 
and the flux of solutes, such as those in the size-range of 
FMLP is asymptotic (Madara and Dharmsathaphorn, 1985; 
Hecht  et  al.,  1988);  that is,  at  higher  resistance  values 
(>200-250  ohm.cm:), large changes in resistance are ac- 
companied by only modest changes in solute flux. The rea- 
sons for this are clear when one considers the behavior of 
a  circuit composed of parallel resistances as we have dis- 
cussed in the past (Madara and Dharmsathaphorn,  1985). 
Such sieving characteristics have other implications for the 
movement of PMN across epithelia (vida infra). 
In this study, we show that the IFN-3,-elicited effects on 
apical-to-basolateral PMN transmigration are dependent on 
new protein synthesis by the epithelial cells. Such findings 
imply that either a soluble or membrane surface protein in- 
duced by IFN-3, exposure may, by direct or indirect means, 
modulate PMN-epithelial interactions. Since IFN-3, effects 
are  apparent after extensive washing of monolayers, and 
since the effects of IFN--t on transmigration cannot be trans- 
ferred to an IFN-3, unexposed monolayer (i.e., by separately 
collecting and applying apical and basolateral solutions to 
new monolayers; our unpublished observations),  it is un- 
likely that the observed effects are due to release of a soluble 
factor. We therefore speculate that an IFN-3,-elicited altera- 
tion in epithelial membrane surface protein(s) may serve as 
the basis for the observed upregulation of apical-to-baso- 
lateral directed PMN  migration brought about by IFN-3,. 
The interaction of PMN with epithelial ceils during trans- 
migration is likely to be a complex, multistep process con- 
sisting of sequential adhesion, deadhesion, and spreading 
events such as has been proposed for transendothelial migra- 
tion (Larson and Springer, 1990;  Osborn, 1990;  Pober and 
Cotran,  1990;  Springer,  1990).  The antiintegrin mAb ex- 
periments suggest, however,  that the additional component 
of transmigration elicited by IFN-'y exposure involves a path- 
way in which CDllb/18-mediated PMN-epithelial interac- 
tion plays a critical role.  These results are comparable to 
transmigration in the basal state, in which CD11b/18 is re- 
quired. Evidence to date suggests that the epithelial counter- 
receptor  for CD11b/18  required  for transmigration in the 
basal state is not any of the known counterreceptors for this 
integrin (Parkos et al., 1991). Similarly, we now find that ap- 
ical CD54  (ICAM-1),  a  potential counterreceptor for this 
integrin (Diamond et al.,  1991) is neither upregulated by 
IFN-3, over the time course in which enhanced transmigra- 
tion occurs,  nor does R6.5  Fab,  which blocks CDllb/18- 
CD54-associated binding (Diamond et al.,  1991), interfere 
with upregulated transmigration in either direction. This ob- 
servation, coupled with the lack of a requirement for serum 
factors in IFN-3,-upregulated transmigration, indicates that 
if new CDllb/18 counterreceptors are induced on the epithe- 
lial surface by IFN--y, they are also likely to be previously 
unrecognized ligands for this integrin. These data, however, 
do not rule out the possibility that ICAM-1 could be upregu- 
lated on the basolateral surface of Ts4 epithelial monolayers. 
Cramer et al.  (1986)  have reported that serum compo- 
nents, likely iC3b, when added to epithelial monolayers at 
the time of transmigration can markedly affect adherence of 
PMN  to  monolayers and  modestly  affect transepithelial 
transmigration of PMN. Preabsorption studies revealed that 
these serum components were extracted by epithelial cells 
within 30 min at 37~  Since serum (5% newborn calf) was 
last placed on the Ts4 monolayers used here 72 h before ex- 
perimentation, and since iC3b covalently linked to surfaces 
is unstable and further degraded to covalently attached prod- 
ucts not known to be CD11b/18 ligands, it is unlikely that the 
effects we report are secondary to IFN--/stimulation of a 
process which activates iC3b binding to the Tu cell sur- 
face. 
IFN-y Modulates PMN Transmigration in the 
Physiological (Basolateral-to-Apical) Direction 
IFN-~/  treatment of epithelial  monolayers affected PMN 
transmigration in a remarkably polarized fashion. Indeed, 
this serves as the first reported qualitative difference in PMN 
transepithelial migration related to the direction of migra- 
tion. The observed IFN--y-elicited downregulation of PMN 
transmigration in the physiological direction was surprising 
in light of the opposite effects observed in apical-to-baso- 
lateral directed transmigration. Such downregulation in the 
physiological direction occurred over a wide range of  applied 
PMN densities, showed graded dose-response characteris- 
tics and time course effects, was dependent on protein syn- 
thesis, and was present at various times during the trans- 
migration  experimental  period.  While  the  net  effect of 
epithelial exposure to  IFN--y  on basolateral-to-apical di- 
rected PMN transmigration was opposite to that of apical-to- 
basolateral transmigration, some similarities existed.  The 
movement of PMN into the monolayer and subsequent PMN 
association with the basolateral membrane of epithelial cells 
appeared to be enhanced by IFN-% However, the subsequent 
movement across the tight  junction and into the apical reser- 
voir was impeded, resulting in a net decrease in total PMN 
transmigration. Experiments using transfer of conditioned 
media, alluded to above, as well as monolayer washing ex- 
periments,  again  suggest  that  soluble  factors  were  not 
responsible for these IFN--/-elicited effects. Thus, it would 
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characteristics of epithelial cells again accounted for the ob- 
served effects. Several possibilities, currently under investi- 
gation,  exist to explain these results.  First,  IFN-3,  could 
differentially  regulate two steps in the sequence of PMN-epi- 
thelial interactions which occur with migration in the phys- 
iological  direction.  An  initial  associative  step  could  be 
upregulated, while a  secondary step before junctional im- 
palement could be  downregulated,  resulting  in enhanced 
movement into the monolayer but overall downregulation of 
PMN transmigration. Alternatively, downregulation of a re- 
quired prejunctional step could simply result in observed ac- 
cumulation of PMN in the epithelial basolateral compart- 
ment. Other possibilities include induction of new ligands 
for PMN or modulation of de-adhesive steps. 
While the polarized differences in IFN--y effects on PMN 
transmigration are of interest, it is clear that basolateral-to- 
apical directed transmigration is physiologically most rele- 
vant.  In this regard, the observed results are of potential 
benefit. The overall effect of IFN-~, exposure for physiologi- 
cally directed migration is to enhance the movement of PMN 
into the subjunctional paracellular space and to prolong the 
residence of the PMN at this site, even in the presence of a 
significant  transjunctional chemotactic gradient. As a result, 
the residence time of the PMN is prolonged at a most crucial 
defensive position: the anatomic subsite at which separation 
of internal from external (lumenal) compartments exist. 
Consideration of the Effects of  Epithelial ~ght 
Junction Permeability on PMN Transmigration 
Junctional permeability is a crucial consideration in such ex- 
periments since, unlike the case in Boyden chambers, or the 
highly permeable endothelial lining of the majority of the 
microcirculation,  epithelial tight junctions have more re- 
strictive permeability characteristics.  For example, the trans- 
epithelial resistance of even "leaky" epithelia is on the order 
of 100 ohm.cm  2, while many epithelia have resistances of 
several  hundred  to  several  thousand  ohm.cm  2  (Powell, 
1981). In contrast, cable analysis studies of the mesenteric 
microvasculature suggests that even physiologically conflu- 
ent endothelium (except for that of the brain which has resis- 
tance >1,000 ohm.cm  2) has an average resistance of only a 
few ohm.cm  2 (on average, <2 ohm.cm2; Crone and Chris- 
tensen, 1981). As a consequence of the capacity of epithelia 
to behave as very restrictive barriers to the passive trans- 
epithelial flux of hydrophilic solutes, one finds that even for 
solutes  with  hydrodynamic radii  in  the  range  of  10  /~, 
diffusional flux across epithelial monolayers, such as those 
used here, is <10 nM/h/cm  2 (Madara and Dharmsathaphorn, 
1985).  Indeed, even in the low resistance state induced by 
prolonged IFN-3,  exposure,  inulin fluxes, while increased 
sixfold from baseline, are <10 nM/h/cm  2 (Madara and Staf- 
ford, 1989).  It is also clear that the intercellular tight junc- 
tion, which in epithelia is continuous, is the specific ana- 
tomic subsite at which the rate-limiting barrier to passive 
paracellular  diffusion resides.  Such  severe  restriction  of 
movement of hydrophilic chemotactic substances in the size 
range of N-formylated peptides implies that across the very 
narrow zone of the epithelial tight junction (<200 nM), ex- 
tremely steep chemotactic gradients can be supported. As a 
consequence, one would expect that, to provide an equiva- 
lent driving force, larger chemotactic gradients would be 
required across epithelia than across  filters (i.e.,  Boyden 
chamber) or confluent endothelia. Similarly, any standard 
chemotactic gradient might more successfully drive migra- 
tion  across  endothelia than  across  epithelia.  Indeed,  as 
shown in this study, when Ca  2§ depletion experiments were 
used to produce discontinuous tight junctions and reduce 
resistances to near that of endothelia, enhancement of trans- 
migration was found. 
Comparative Evaluation of Transendothelial and 
Transepithelial Migration of  PMN 
As outlined in the introduction and as derived from model 
systems, PMN interactions with epithelia, including specific 
interactions with epithelial apical membranes after trans- 
migration, modulate epithelial function. Hence, a better un- 
derstanding of the rules governing PMN-epithelial interac- 
tions and transmigration are crucial to the understanding of 
active inflammation at mucosal surfaces. Additionally, if the 
rules vary between transepithelial and transendothelial mi- 
gration of PMN,  possibilities for new (and perhaps  even 
more specific) therapeutic strategies would exist.  For this 
reason, it is useful to consider what appears to be emerging 
differences in transmigration across these two crucial bar- 
riers. This comparison chiefly relies on studies derived from 
model human intestinal epithelium, and it is possible that 
organ- and site-specific differences in PMN-epithelial inter- 
actions exist. Also, since basal endothelial-neutrophil inter- 
actions are difficult to access because of small signal size, 
this comparison largely relies on data obtained from cyto- 
kine-activated endothelial cells. 
We have found no differences in baseline electrical param- 
eters across Tg4 monolayers nor differences in subsequent 
PMN transmigration in monolayers kept in strict endotoxin- 
free conditions and subsequently exposed to endotoxin for 
various periods up to 6 h (Nash, S., J. L. Madara, and J. 
Stafford, unpublished observations). In contrast, endothelial 
cells are extremely sensitive to endotoxin and respond by ex- 
pression of endothelial surface markers which define the ac- 
tivated state of enhanced PMN adherence (Pohlman et al., 
1987; Wellicome et al.,  1990).  Since endotoxin constantly 
bathes  intestinal epithelia under physiological conditions, 
endothelial exposure to endotoxin primarily occurs in as- 
sociation with adjacent bacterial disease, Such differences in 
endotoxin effects on these systems would, in a teleological 
sense, seem wholly appropriate. Differences in the participa- 
tion  of integrins may also  exist between  endotbelia and 
epithelia.  /~2-integrin-mediated  adhesion  of PMN  to  en- 
dothelial cells  appears  to be  a  required  step  in transen- 
dothelial migration ofPMN (Larson and Springer, 1990; Os- 
born,  1990;  Pober  and  Cotran,  1990;  Springer,  1990). 
However,  with endothelia, depending on the conditions of 
activation  of  endothelial  cells  and  PMN,  CDlla/18  or 
CDlla/18 and CDllb/18 contribute in significant fashion to 
PMN interactions (Smith et al.,  1989).  In contrast, under 
basal or IFN-3,-induced states, we find no evidence for a 
significant role of CDlla/18 in PMN transmigration across 
our model intestinal epithelium. Substantial differences (as 
well as similarities) exist in model endothelial and model in- 
testinal epithelial responses to IFN-3,. In both models, IFN-~ 
alters F-actin distribution (Stolpen et al., 1986; Madara and 
Stafford, 1989), and induces expression of MHC class H an- 
tigens on the plasma membrane (Collins et al., 1988; Mayer 
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in F-actin distribution parallel alterations  in tight junction 
permeability  (Madara and Stafford,  1989),  although it has 
not been assessed whether comparable functional changes 
occur with the comparable cytoskeletal alterations noted in 
endothelia. However, while IFN-T induces CD54 (ICAM-1) 
expression on endothelia (Pober et al., 1986), we find no evi- 
dence  for IFN-3,-mediated  induction of apical  ICAM-1  in 
our intestinal epithelial model.  Of interest,  in vivo studies 
in mice have shown that the epithelium for which T~ cells 
serve as a model-colonic crypt cells-are not induced to ex- 
press MHC class II equivalents by IFN--y, even though some 
other epithelia (including villus enterocytes) are so induced 
(Momberg et al.,  1986).  Finally, IFN-3, substantially influ- 
ences PMN-epithelial  interactions, and does so in a highly 
polarized fashion, but does not appear to substantially effect 
PMN-endothelial  interactions  unless  coexposed  to  other 
cytokines (Pober and Cotran, 1990). In aggregate, the above 
data suggest that substantial differences  will exist between 
PMN  interactions  with  endothelia  and  epithelia.  Since 
PMN-epithelial  interactions  occurring  in  transepithelial 
migration likely appear to contribute to mucosal dysfunction 
in active inflammatory states (vida supra), a better under- 
standing of the unique rules governing epithelial-neutrophil 
interactions may open the door to more tissue-specific thera- 
pies in the future. 
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